This article was originally published in The Tan Sheet
U.S. Pharmacopeia is not spending $20 mil. to support its Dietary Supplement Verification Program, as reported in 1"The Tan Sheet" Oct. 14, 2002, p. 15; the figure was an estimate of how much it might cost to effectively reach the general public. USP also is not receiving any outside funding to promote its program in trade journals and educational brochures. Companies whose products are certified by USP may independently promote the seal as they see fit...
You may also be interested in...
The U.S. Pharmacopeia plans to spend approximately $20 mil. on an educational campaign to support the launch of its Dietary Supplement Verification Program
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.